{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:03:17Z","timestamp":1778900597413,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jiac.2017.03.007","type":"journal-article","created":{"date-parts":[[2017,4,23]],"date-time":"2017-04-23T07:45:52Z","timestamp":1492933552000},"page":"385-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha, China"],"prefix":"10.1016","volume":"23","author":[{"given":"Ting","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2017.03.007_bib1","unstructured":"WHO. Global incidence and prevalence of selected curable sexually transmitted infections-2008. Geneva: WHO.http:\/\/www.who.int\/reproducti-vehealth\/publications\/rtis\/2008_STI_estimates.pdf."},{"key":"10.1016\/j.jiac.2017.03.007_bib2","unstructured":"Chinese CDC. Reports from National STI surveillance System in China-2012. Nanjing: Chinese CDC. http:\/\/www.ncstdc.org\/upfiles\/201303\/201303-19152506703."},{"key":"10.1016\/j.jiac.2017.03.007_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion","volume":"53","author":"Bernstein","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jiac.2017.03.007_bib4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/sextrans-2012-050904","article-title":"Monitoring antimicrobial resistance in Neisseria gonorrhoeae in selected countries of the WHO South-East Asia Region between 2009 and 2012: a retrospective analysis","volume":"89","author":"Bala","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jiac.2017.03.007_bib5","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","article-title":"Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?Detailed characterization of the first strain with high-level resistance to ceftriaxone","volume":"55","author":"Ohnishi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime and ceftriaxone resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001598","article-title":"Molecular diagnostics for gonorrhoea implications for antimicrobial resistance and the threat of untreatable gonorrhea","volume":"11","author":"Low","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/j.jiac.2017.03.007_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrmicro3217","article-title":"Molecular approaches to enhance surveillance of gonococcal antimicrobial resistance","volume":"12","author":"Namraj Goire,Monica","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jiac.2017.03.007_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12879-016-1469-3","article-title":"Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou,China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics","volume":"16","author":"Liang","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2017.03.007_bib10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jac\/dkr021","article-title":"Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone","volume":"66","author":"Liao","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib11","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/jac\/dku245","article-title":"Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing,China","volume":"69","author":"Chen","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib12","first-page":"92","volume":"vol. 31","author":"Clinical and Laboratory Standards Institute (CLSI) Document M100-S21","year":"2011"},{"key":"10.1016\/j.jiac.2017.03.007_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jac\/dkv321","article-title":"First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China","volume":"71","author":"Chen","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib14","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/AAC.00306-07","article-title":"Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone","volume":"51","author":"Whiley","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib15","doi-asserted-by":"crossref","first-page":"e00187","DOI":"10.1128\/mBio.00187-11","article-title":"A\u00a0novel mechanism of high level broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae","volume":"2","author":"Ohneck","year":"2011","journal-title":"MBio"},{"key":"10.1016\/j.jiac.2017.03.007_bib16","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/AAC.00626-06","article-title":"Amino acid substitutions of mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae","volume":"50","author":"Takahata","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jac\/dkq187","article-title":"Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2","volume":"65","author":"Whiley","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib18","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jac\/dkt543","article-title":"Unique combined penA\/mtrR\/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a \u2018susceptible\u2019 Neisseria gonorrhoeae population","volume":"69","author":"Hakur","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1128\/AAC.46.3.769-777.2002","article-title":"Mutations in ponA, the gene encoding penicillin-binding protein1, and a novel locus, penC, are required for high-level chromosomally mediated penicillin resistance in Neisseria gonorrhoeae","volume":"46","author":"Ropp","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib20","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.00198-08","article-title":"Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection","volume":"52","author":"Lo","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib21","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","article-title":"Mosaic-like structure of penicillin-binding protein 2 gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime","volume":"46","author":"Ameyama","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2017.03.007_bib22","first-page":"16","article-title":"Gonorrhoea treatment failures to cefixime and azithromycin in England","volume":"2011","author":"Ison","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2017.03.007_bib23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1136\/sti.2010.045377","article-title":"Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in\u00a0vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden","volume":"86","author":"Golparian","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jiac.2017.03.007_bib24","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jiac.2017.03.007_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1001\/jama.2012.176575","article-title":"Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada","volume":"309","author":"Allen","year":"2013","journal-title":"JAMA"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X17300545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:56:16Z","timestamp":1761159376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X17300545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1341321X17300545"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2017.03.007","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftriaxone susceptibility and molecular characteristics of Neisseria gonorrhoeae isolates in Changsha, China","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2017.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}